CRTX — CRISM Therapeutics Share News
0.000.00%
- £3.50m
- £3.15m
- £0.03m
REG - CRISM Therapeutics - Establishment of Scientific Advisory Board
AnnouncementREG - CRISM Therapeutics - Director Dealing
AnnouncementREG - CRISM Therapeutics - Clinical Trial Update
AnnouncementREG - CRISM Therapeutics - Innovate UK Grant Award
AnnouncementREG - CRISM Therapeutics - Appointment of Specialist Clinical CRO
AnnouncementREG - CRISM Therapeutics - European Patent Grant
AnnouncementREG - CRISM Therapeutics - Interim Results
AnnouncementREG - CRISM Therapeutics - Notice of Interim Results & IMC Presentation
AnnouncementRCS - CRISM Therapeutics - Delivery Method Validated in Peer Reviewed Journal
AnnouncementREG - CRISM Therapeutics - Innovation Passport Award
AnnouncementREG - Crism Therapeutics - CRISM Signs Service Agreement Contract
AnnouncementREG - Crism Therapeutics - Response to Movement in Share Price
AnnouncementREG - Crism Therapeutics - Director Dealing
AnnouncementREG - Crism Therapeutics - Admission to Trading and First Day of Dealings
Announcement